Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Headwinds to tailwinds w/patient counts up? Combo partners +

<< Previous

Bullboard Posts

Next >>

Comment by Kd5513on Apr 12, 2023 3:27pm

63 Views

Post# 35391390

RE:Headwinds to tailwinds w/patient counts up? Combo partners +

Thanks for thorough post Wino, always to nice to see you and many others who are very sharp thoughts. Breathes a little bit of confidence back in this.

However, something that simple for an outsider who is very sharp to put together in one day, why cant this leadership team at THTX do anything close to that type of communication?

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price